21 C.F.R. § 862.1335

Glucagon test system.

Last amended: 2016Year: 2026Length: 86 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1335 (2026)

(a) Identification. A glucagon test system is a device intended to measure the pancreatic hormone glucagon in plasma and serum. Glucagon measurements are used in the diagnosis and treatment of patients with various disorders of carbohydrate metabolism, including diabetes mellitus, hypoglycemia, and hyperglycemia. (b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9. [52 FR 16122, May 1, 1987, as amended at 65 FR 2306, Jan. 14, 2000]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1335: Glucagon test system. | Justis AI